DePuy Lawyers
DePuy ASR Hip Implant Recall DePuy News DePuy Pinnacle Lawyers Attorneys Fees Contact Us
DePuy ASR Hip Implant Lawsuit
DePuy News
DePuy Pinnacle Lawyers
33⅓% Contingent Fee
Contact Us
Johnson & Johnson announced a recall of the DePuy ASR hip device due to a high failure rate following implant. Follow the latest news on lawsuits and settlements involving the DePuy ASR Hip Replacement. Our lawyers also represent people harmed by the DePuy Pinnacle® hip device. Many law firms charge percentage fees as high as 45%. We charge 33⅓% and we're paid only if we win your case and you collect. If you or a loved one has been injured as a result of a DePuy ASR hip device, contact us to discuss your legal rights.
DePuy Lawsuit
 

DePuy ASR Hip Replacement Lawsuit

Lawyers Represent People Harmed by DePuy ASR Hip Implant

O'Steen & Harrison Files Lawsuit On Behalf of Arizona Woman Injured by Defective DePuy Hip Replacement

January 25, 2011—Jacqueline Chamberlin filed a lawsuit against Johnson & Johnson and its subsidiary DePuy Orthopaedics in Superior Court in San Francisco, California. The lawsuit alleges that the manufacturers sold the ASR™ XL Acetabular System for more than five years, while receiving and concealing repeated warnings of aberrantly high failure rates.

Last August, DePuy voluntarily recalled its ASR™ XL Acetabular System hip replacement after a report published in the United Kingdom revealed that an abnormally large number of patients needed corrective surgery within five years of implantation.

We encourage you to learn more about the lawsuit against DePuy Orthopaedics and Johnson & Johnson.

depuy asr recall

Johnson & Johnson Announces Recall of Defective DePuy ASR Hip Replacement

August 24, 2010—Johnson & Johnson's joint replacement business, DePuy Orthopaedics, Inc., announced a voluntary recall of its ASR™ XL Acetabular System hip replacement following a report published in Great Britain which revealed that about one in every eight patients required corrective surgery within five years of implantation. Specifically, the revision rate for the ASR™ Hip Resurfacing System is 12 percent and for the ASR™ XL Acetabular System is 13 percent.

Since early 2008, the Federal Food and Drug Administration (FDA) has received hundreds of complaints about DePuy ASR™ Implants. Most of these patients required removal and replacement of the devices following their implantation.

Orthopedic experts say the problem with the DePuy implant rests primarily in the design of the ASR™ hip replacement cup. It is more shallow that other hip replacement devices. In addition the ASR™ cup has been found to be more difficult for surgeons to implant at the proper angle.

Because the DePuy Implants are metal-on-metal total hip replacement units, they can produce metallic particles as they age and wear. The result in some patients is severe inflammatory reaction which may damage surrounding soft tissue.

Both DePuy hip replacement devices were implanted in patients between 2003 and 2009, when Johnson & Johnson ceased production of them. More than 90,000 DePuy hip implants were sold worldwide before production was discontinued. Based on the documented failure rates for the devices, it is anticipated as many as 11,000 patients will eventually require painful and disabling hip replacement surgeries to remove the defective DePuy implants and replace them with other units. Many patients who received the ASR™ hip implants are likely to eventually require explantation of the devices even though they are presently symptom free. All patients with these DePuy implants are encouraged to promptly consult their physicians for evaluation and to arrange for future monitoring.

In connection with the recall, DePuy announced it will reimburse implant patients for reasonable medical expenses, but only if they sign medical release forms giving the company broad access to their personal and otherwise private medical records. Furthermore, these reimbursements are greatly limited in that they extend only to out-of-pocket costs that are not covered by the patient's medical insurance. There is no compensation for pain and suffering, disability, nerve or tissue damage or any loss of income associated with the defective DePuy hip implants.

For these reasons, we encourage all DePuy hip replacement patients to consult with a lawyer who is experienced in dangerous medical device litigation before attempting to deal directly with DePuy or Johnson & Johnson.

Your Health

What You Should Do

Your Health

If you have a DePuy ASR hip device, promptly consult your physician for an evaluation.

Your Legal Rights

If you have received a DePuy ASR hip device, you may be entitled to compensation. You should act immediately to contact a lawyer experienced in matters involving defective medical devices.
DePuy Lawyers

Our DePuy Lawyers Can Help

O'Steen & Harrison, PLC is handling legal claims on behalf of those harmed by the DePuy ASR hip replacement system. We invite you to contact us for a free, confidential consultation about your legal rights.

We represent patients throughout the United States. We can help you, too, wherever you live.

For free answers to your questions about how our lawyers can help if you have been harmed by a defective DePuy ASR hip replacement, please call us toll-free at 1-800-883-8888 or complete this online contact form.

Highest Rated Law Firms

O'Steen & Harrison, PLC

300 W. Clarendon Ave., Suite 400
Phoenix, Arizona 85013-3424

800.883.8888
info@vanosteen.com

Our Attorneys

Our lawyers represent people harmed by the following hip replacement devices:

Contact Us

Name
Phone
Email
 

Why You Should Choose Us

We have represented thousands of people, including some of the largest and most important injury cases ever brought in the United States.

In the single largest damages case in the history of the world, our attorneys were selected by the Arizona Attorney General as the only Arizona law firm to represent the State against American tobacco companies. As a result, Arizona taxpayers will receive more than three billion dollars to cover the costs of treating tobacco-related illnesses, maintain educational programs to prevent young people from smoking, and fund other important State programs.

Johnson & Johnson Reserves $992 Million for Settlements, Lawsuit Costs
Van O'Steen • January 26, 2011
 
DePuy Attorney Van O'Steen
Johnson & Johnson released financial disclosure statements this week revealing it has reserved $992 million for a settlement fund and to cover litigation expenses related to its defective DePuy ASR™ XL Acetabular System.
 
Lawsuits Against DePuy Hip Implant Manufacturer Grow
Jonathan V. O'Steen • January 25, 2011
 
DePuy Attorney Jon O'Steen
Jacqueline Chamberlin of Scottsdale, Arizona sued Johnson & Johnson and its subsidiary DePuy Orthopaedics in Superior Court in San Francisco, California. The lawsuit alleges that the manufacturers sold the ASR™ XL Acetabular System for more than five years, while receiving and concealing repeated warnings of aberrantly high failure rates.